Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2025-12-28 @ 9:44 PM
Study NCT ID:
NCT04712903
Status:
COMPLETED
Last Update Posted:
2025-01-07
First Post:
2020-12-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung Cancer
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-16
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-21
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-03
First Submit QC Date:
None
Study First Post Date:
2021-01-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-06-19
Results First Submit QC Date:
None
Results First Post Date:
2025-01-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-13
Last Update Post Date:
2025-01-07
Last Update Post Date Type:
ACTUAL